Randomized Phase Ⅲ Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus as First-Line Endocrine Therapy in Postmenopausal Women with Locally Advanced or Metastatic Breast Cancer

LIU Jian; HUANG Wei-wei; QIAN  Xue-ke

doi:10.3969/j.issn.1671-5144.2013.03.004

LIU Jian, HUANG Wei-wei, QIAN Xue-ke. Randomized Phase Ⅲ Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus as First-Line Endocrine Therapy in Postmenopausal Women with Locally Advanced or Metastatic Breast Cancer[J]. Journal of Evidence-Based Medicine, 2013, 13(3): 135-137. DOI: 10.3969/j.issn.1671-5144.2013.03.004

Citation:

LIU Jian, HUANG Wei-wei, QIAN Xue-ke. Randomized Phase Ⅲ Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus as First-Line Endocrine Therapy in Postmenopausal Women with Locally Advanced or Metastatic Breast Cancer[J]. Journal of Evidence-Based Medicine, 2013, 13(3): 135-137. DOI: 10.3969/j.issn.1671-5144.2013.03.004

Citation:

LIU Jian, HUANG Wei-wei, QIAN Xue-ke. Randomized Phase Ⅲ Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus as First-Line Endocrine Therapy in Postmenopausal Women with Locally Advanced or Metastatic Breast Cancer[J]. Journal of Evidence-Based Medicine, 2013, 13(3): 135-137. DOI: 10.3969/j.issn.1671-5144.2013.03.004

Randomized Phase Ⅲ Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus as First-Line Endocrine Therapy in Postmenopausal Women with Locally Advanced or Metastatic Breast Cancer

Graphical Abstract

Abstract

FullText(HTML)

References (0)

Randomized Phase Ⅲ Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus as First-Line Endocrine Therapy in Postmenopausal Women with Locally Advanced or Metastatic Breast Cancer

Catalog

Export File

Citation

Format

Content